Campus Activewear Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 3, 2025, 11:57 pm

Quick Insight

Campus Activewear Ltd, a leading footwear company, currently trades at ₹283 with a market capitalization of ₹8,656 Cr. The company's Price-to-Earnings ratio stands at 73.4, reflecting a premium valuation compared to the sector average of around 40. However, Campus Activewear's Return on Equity at 17.2% and Return on Capital Employed at 20.1% outperform industry benchmarks, indicating efficient utilization of resources. With Operating Profit Margin at 18% and a healthy Net Profit of ₹121 Cr, the company demonstrates strong profitability metrics.

One key strength of Campus Activewear is its robust shareholder base, with promoters holding a significant stake of 72.13%. Additionally, the company's comfortable Interest Coverage Ratio of 12.43x suggests a healthy ability to service its debt obligations. However, risks lie in its high Price-to-Book Value of N/Ax, potentially signaling overvaluation, and a Cash Conversion Cycle of 118 days, which could indicate inefficiencies in working capital management. Looking ahead, Campus Activewear's outlook could improve by focusing on reducing its CCC to enhance liquidity and implementing strategies to improve its P/BV ratio, thereby aligning its valuation more closely with industry peers.

In conclusion, while Campus Activewear exhibits strong financial performance and shareholder support, investors should closely monitor its valuation metrics and working capital efficiency to mitigate potential risks and capitalize on future growth opportunities in the competitive footwear industry.

Competitors of Campus Activewear Ltd

All Competitor Stocks of Campus Activewear Ltd

Quarterly Result

Last Updated: July 16, 2025, 10:30 am

Below is a detailed analysis of the quarterly data for Campus Activewear Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 406.00 Cr.. The value appears to be declining and may need further review. It has decreased from 515.00 Cr. (Dec 2024) to 406.00 Cr., marking a decrease of 109.00 Cr..
• For Expenses, as of Mar 2025, the value is 334.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 433.00 Cr. (Dec 2024) to 334.00 Cr., marking a decrease of 99.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 71.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Dec 2024) to 71.00 Cr., marking a decrease of 11.00 Cr..
• For OPM %, as of Mar 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 18.00%, marking an increase of 2.00%.
• For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Dec 2024) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 23.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Dec 2024) to 23.00 Cr., marking an increase of 4.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Dec 2024) to 48.00 Cr., marking a decrease of 15.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 26.00%.
• For Net Profit, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Dec 2024) to 35.00 Cr., marking a decrease of 11.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.15. The value appears to be declining and may need further review. It has decreased from 1.52 (Dec 2024) to 1.15, marking a decrease of 0.37.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:23 pm

Growth

Last Updated: September 5, 2025, 2:46 pm

Balance Sheet

Last Updated: September 10, 2025, 3:16 pm

Below is a detailed analysis of the balance sheet data for Campus Activewear Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 153.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 153.00 Cr..
• For Reserves, as of Mar 2025, the value is 604.00 Cr.. The value appears strong and on an upward trend. It has increased from 499.00 Cr. (Mar 2024) to 604.00 Cr., marking an increase of 105.00 Cr..
• For Borrowings, as of Mar 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 178.00 Cr. (Mar 2024) to 232.00 Cr., marking an increase of 54.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 339.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 286.00 Cr. (Mar 2024) to 339.00 Cr., marking an increase of 53.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,115.00 Cr. (Mar 2024) to 1,328.00 Cr., marking an increase of 213.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 430.00 Cr.. The value appears strong and on an upward trend. It has increased from 354.00 Cr. (Mar 2024) to 430.00 Cr., marking an increase of 76.00 Cr..
• For CWIP, as of Mar 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2024) to 34.00 Cr., marking an increase of 14.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 863.00 Cr.. The value appears strong and on an upward trend. It has increased from 741.00 Cr. (Mar 2024) to 863.00 Cr., marking an increase of 122.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,115.00 Cr. (Mar 2024) to 1,328.00 Cr., marking an increase of 213.00 Cr..

Notably, the Reserves (604.00 Cr.) exceed the Borrowings (232.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Campus Activewear Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 22, the value is 5.00. This value is within the healthy range. It has decreased from 10.00 (Mar 21) to 5.00, marking a decrease of 5.00.
• For Basic EPS (Rs.), as of Mar 22, the value is 3.57. This value is below the healthy minimum of 5. It has increased from 0.88 (Mar 21) to 3.57, marking an increase of 2.69.
• For Diluted EPS (Rs.), as of Mar 22, the value is 3.57. This value is below the healthy minimum of 5. It has increased from 0.88 (Mar 21) to 3.57, marking an increase of 2.69.
• For Cash EPS (Rs.), as of Mar 22, the value is 5.29. This value is within the healthy range. It has increased from 3.92 (Mar 21) to 5.29, marking an increase of 1.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 14.05. It has decreased from 20.61 (Mar 21) to 14.05, marking a decrease of 6.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 14.05. It has decreased from 20.61 (Mar 21) to 14.05, marking a decrease of 6.56.
• For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 39.24. It has decreased from 46.83 (Mar 21) to 39.24, marking a decrease of 7.59.
• For PBDIT / Share (Rs.), as of Mar 22, the value is 8.02. This value is within the healthy range. It has increased from 7.89 (Mar 21) to 8.02, marking an increase of 0.13.
• For PBIT / Share (Rs.), as of Mar 22, the value is 6.27. This value is within the healthy range. It has increased from 5.74 (Mar 21) to 6.27, marking an increase of 0.53.
• For PBT / Share (Rs.), as of Mar 22, the value is 5.62. This value is within the healthy range. It has increased from 4.61 (Mar 21) to 5.62, marking an increase of 1.01.
• For Net Profit / Share (Rs.), as of Mar 22, the value is 3.54. This value is within the healthy range. It has increased from 1.77 (Mar 21) to 3.54, marking an increase of 1.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 3.57. This value is within the healthy range. It has increased from 1.77 (Mar 21) to 3.57, marking an increase of 1.80.
• For PBDIT Margin (%), as of Mar 22, the value is 20.42. This value is within the healthy range. It has increased from 16.84 (Mar 21) to 20.42, marking an increase of 3.58.
• For PBIT Margin (%), as of Mar 22, the value is 15.97. This value is within the healthy range. It has increased from 12.24 (Mar 21) to 15.97, marking an increase of 3.73.
• For PBT Margin (%), as of Mar 22, the value is 14.32. This value is within the healthy range. It has increased from 9.83 (Mar 21) to 14.32, marking an increase of 4.49.
• For Net Profit Margin (%), as of Mar 22, the value is 9.02. This value is within the healthy range. It has increased from 3.77 (Mar 21) to 9.02, marking an increase of 5.25.
• For NP After MI And SOA Margin (%), as of Mar 22, the value is 9.08. This value is within the healthy range. It has increased from 3.77 (Mar 21) to 9.08, marking an increase of 5.31.
• For Return on Networth / Equity (%), as of Mar 22, the value is 25.38. This value is within the healthy range. It has increased from 8.59 (Mar 21) to 25.38, marking an increase of 16.79.
• For Return on Capital Employeed (%), as of Mar 22, the value is 32.89. This value is within the healthy range. It has increased from 20.72 (Mar 21) to 32.89, marking an increase of 12.17.
• For Return On Assets (%), as of Mar 22, the value is 11.30. This value is within the healthy range. It has increased from 3.92 (Mar 21) to 11.30, marking an increase of 7.38.
• For Long Term Debt / Equity (X), as of Mar 22, the value is 0.10. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 21) to 0.10, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 22, the value is 0.40. This value is within the healthy range. It has decreased from 0.43 (Mar 21) to 0.40, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 22, the value is 1.45. It has increased from 1.18 (Mar 21) to 1.45, marking an increase of 0.27.
• For Current Ratio (X), as of Mar 22, the value is 1.59. This value is within the healthy range. It has increased from 1.45 (Mar 21) to 1.59, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 22, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 21) to 0.65, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 22, the value is 2.44. This value is below the healthy minimum of 4. It has increased from 1.90 (Mar 21) to 2.44, marking an increase of 0.54.
• For Interest Coverage Ratio (X), as of Mar 22, the value is 12.43. This value is within the healthy range. It has increased from 6.98 (Mar 21) to 12.43, marking an increase of 5.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 6.49. This value is within the healthy range. It has increased from 2.57 (Mar 21) to 6.49, marking an increase of 3.92.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness